Rosenwald A - Search Results

1

EMT, Stemness, and Drug Resistance in Biological Context: A 3D Tumor Tissue/In Silico Platform for Analysis of Combinatorial Treatment in NSCLC with Aggressive KRAS-Biomarker Signatures.

Peindl M, Göttlich C, Crouch S, Hoff N, Lüttgens T, Schmitt F, Pereira JGN, May C, Schliermann A, Kronenthaler C, Cheufou D, Reu-Hofer S, Rosenwald A, Weigl E, Walles T, Schüler J, Dandekar T, Nietzer S, Dandekar G. Peindl M, et al. Among authors: rosenwald a. Cancers (Basel). 2022 Apr 27;14(9):2176. doi: 10.3390/cancers14092176. Cancers (Basel). 2022. PMID: 35565305 Free PMC article.

2

Identifying functional modules in protein-protein interaction networks: an integrated exact approach.

Dittrich MT, Klau GW, Rosenwald A, Dandekar T, Müller T. Dittrich MT, et al. Among authors: rosenwald a. Bioinformatics. 2008 Jul 1;24(13):i223-31. doi: 10.1093/bioinformatics/btn161. Bioinformatics. 2008. PMID: 18586718 Free PMC article.

3

Exon-4 Mutations in KRAS Affect MEK/ERK and PI3K/AKT Signaling in Human Multiple Myeloma Cell Lines.

Weißbach S, Heredia-Guerrero SC, Barnsteiner S, Großhans L, Bodem J, Starz H, Langer C, Appenzeller S, Knop S, Steinbrunn T, Rost S, Einsele H, Bargou RC, Rosenwald A, Stühmer T, Leich E. Weißbach S, et al. Among authors: rosenwald a. Cancers (Basel). 2020 Feb 16;12(2):455. doi: 10.3390/cancers12020455. Cancers (Basel). 2020. PMID: 32079091 Free PMC article.

4

Targeted Deep Sequencing of Mycosis Fungoides Reveals Intracellular Signaling Pathways Associated with Aggressiveness and Large Cell Transformation.

Wobser M, Roth S, Appenzeller S, Houben R, Schrama D, Goebeler M, Geissinger E, Rosenwald A, Maurus K. Wobser M, et al. Among authors: rosenwald a. Cancers (Basel). 2021 Nov 2;13(21):5512. doi: 10.3390/cancers13215512. Cancers (Basel). 2021. PMID: 34771672 Free PMC article.

5

Explorative data analysis of MCL reveals gene expression networks implicated in survival and prognosis supported by explorative CGH analysis.

Blenk S, Engelmann JC, Pinkert S, Weniger M, Schultz J, Rosenwald A, Müller-Hermelink HK, Müller T, Dandekar T. Blenk S, et al. Among authors: rosenwald a. BMC Cancer. 2008 Apr 16;8:106. doi: 10.1186/1471-2407-8-106. BMC Cancer. 2008. PMID: 18416826 Free PMC article.

6

Germinal center B cell-like (GCB) and activated B cell-like (ABC) type of diffuse large B cell lymphoma (DLBCL): analysis of molecular predictors, signatures, cell cycle state and patient survival.

Blenk S, Engelmann J, Weniger M, Schultz J, Dittrich M, Rosenwald A, Müller-Hermelink HK, Müller T, Dandekar T. Blenk S, et al. Among authors: rosenwald a. Cancer Inform. 2007 Dec 12;3:399-420. Cancer Inform. 2007. PMID: 19455257 Free PMC article.

7

Targeting CXCR4 with [⁶⁸Ga]Pentixafor: a suitable theranostic approach in pleural mesothelioma?

Lapa C, Kircher S, Schirbel A, Rosenwald A, Kropf S, Pelzer T, Walles T, Buck AK, Weber WA, Wester HJ, Herrmann K, Lückerath K. Lapa C, et al. Among authors: rosenwald a. Oncotarget. 2017 May 27;8(57):96732-96737. doi: 10.18632/oncotarget.18235. eCollection 2017 Nov 14. Oncotarget. 2017. PMID: 29228566 Free PMC article.

8

Thymic Hyperplasia with Lymphoepithelial Sialadenitis (LESA)-Like Features: Strong Association with Lymphomas and Non-Myasthenic Autoimmune Diseases.

Porubsky S, Popovic ZV, Badve S, Banz Y, Berezowska S, Borchert D, Brüggemann M, Gaiser T, Graeter T, Hollaus P, Huettl KS, Kotrova M, Kreft A, Kugler C, Lötscher F, Möller B, Ott G, Preissler G, Roessner E, Rosenwald A, Ströbel P, Marx A. Porubsky S, et al. Among authors: rosenwald a. Cancers (Basel). 2021 Jan 16;13(2):315. doi: 10.3390/cancers13020315. Cancers (Basel). 2021. PMID: 33467055 Free PMC article.

9

Frequency of regulatory T cells determines the outcome of the T-cell-engaging antibody blinatumomab in patients with B-precursor ALL.

Duell J, Dittrich M, Bedke T, Mueller T, Eisele F, Rosenwald A, Rasche L, Hartmann E, Dandekar T, Einsele H, Topp MS. Duell J, et al. Among authors: rosenwald a. Leukemia. 2017 Oct;31(10):2181-2190. doi: 10.1038/leu.2017.41. Epub 2017 Jan 25. Leukemia. 2017. PMID: 28119525 Free PMC article.

10

JAM-A as a prognostic factor and new therapeutic target in multiple myeloma.

Solimando AG, Brandl A, Mattenheimer K, Graf C, Ritz M, Ruckdeschel A, Stühmer T, Mokhtari Z, Rudelius M, Dotterweich J, Bittrich M, Desantis V, Ebert R, Trerotoli P, Frassanito MA, Rosenwald A, Vacca A, Einsele H, Jakob F, Beilhack A. Solimando AG, et al. Among authors: rosenwald a. Leukemia. 2018 Mar;32(3):736-743. doi: 10.1038/leu.2017.287. Epub 2017 Sep 28. Leukemia. 2018. PMID: 29064484 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

779 results

Search Page